Breast Cancer in Bobo-Dioulasso, Burkina Faso: Management OutcomesLe Cancer du Sein �Bobo-Dioulasso, Burkina Faso : R閟ultats de la Prise en Charge

Konkobo, Ollo Roland Som� Abdoul Halim Bagu� Damien; Dieudonn�Hien,; B閘emlilga, Adama Demb閘� GL Hermann; Zongo, Valentin Kons間r� Nayi

doi:10.32604/oncologie.2022.021250

Oncologie

2022

DOI: 10.32604/oncologie.2022.021250

|View full text |Cite

Breast Cancer in Bobo-Dioulasso, Burkina Faso: Management OutcomesLe Cancer du Sein �Bobo-Dioulasso, Burkina Faso : R閟ultats de la Prise en Charge

Ollo Roland Som� Abdoul Halim Bagu� Damien Konkobo¹,

Dieudonn�Hien Dieudonn�Hien²,

Adama Demb閘� GL Hermann B閘emlilga³

et al.

Abstract: Introduction : La prise en charge du cancer du sein en Afrique subsaharienne est confrontée à des difficultés diagnostiques et thérapeutiques. Objectif : Décrire le profil clinique, thérapeutique et évolutif du cancer du sein au Burkina Faso. Patients et méthodes : Il s'agit d'une étude de cohorte rétrospective du 1er Juillet 2015 au 31 Décembre 2021 au CHU Sourô Sanou à Bobo Dioulasso, 2ème ville du Burkina Faso. Elle a porté sur les données cliniques, thérapeutiques et évolutives des cancers du sein, confirm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa

Limenih,

Mekonnen,

Birhanu

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceBreast cancer is the most prevalent cancer globally with tremendous disparities both within specific regions and across different contexts. The survival pattern of patients with breast cancer remains poorly understood in sub-Saharan African (SSA) countries.ObjectiveTo investigate the survival patterns of patients with breast cancer in SSA countries and compare the variation across countries and over time.Data SourcesEmbase, PubMed, Web of Science, Scopus, and ProQuest were searched from inception to December 31, 2022, with a manual search of the references.Study SelectionCohort studies of human participants that reported 1-, 2-, 3-, 4-, 5-, and 10-year survival from diagnosis among men, women, or both with breast cancer in SSA were included.Data Extraction and SynthesisIndependent extraction of study characteristics by multiple observers was performed using open-source software, then exported to a standard spreadsheet. A random-effects model using the generalized linear mixed-effects model was used to pool data. The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guideline for reporting was followed.Main Outcome and MeasuresSurvival time from diagnosis.ResultsForty-nine studies were included in the review with a sample size ranging from 21 to 2311 (total, 14 459; 196 [1.35%] men, 13 556 [93.75%] women, and 707 [4.90%] unspecified; mean age range, 38 to 71 years), of which 40 were summarized using meta-analysis. The pooled 1-year survival rate of patients with breast cancer in SSA was 0.79 (95% CI, 0.67-0.88); 2-year survival rate, 0.70 (95% CI, 0.57-0.80); 3-year survival rate, 0.56 (95% CI, 0.45-0.67); 4-year survival rate, 0.54 (95% CI, 0.43-0.65); and 5-year survival rate, 0.40 (95% CI, 0.32-0.49). The subgroup analysis showed that the 5-year survival rate ranged from 0.26 (95% CI, 0.06-0.65) for studies conducted earlier than 2010 to 0.47 (95% CI, 0.32-0.64) for studies conducted later than 2020. Additionally, the 5-year survival rate was lower in countries with a low human development index (HDI) (0.36 [95% CI, 0.25-0.49) compared with a middle HDI (0.46 [95% CI, 0.33-0.60]) and a high HDI (0.54 [95% CI, 0.04-0.97]).Conclusions and RelevanceIn this systematic review and meta-analysis, the survival rates for patients with breast cancer in SSA were higher in countries with a high HDI compared with a low HDI. Enhancing patient survival necessitates a comprehensive approach that involves collaboration from all relevant stakeholders.

show abstract

Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa

Limenih,

Mekonnen,

Birhanu

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

show abstract

The quality of life among women with breast cancer: a qualitative study in the environment of healthcare in Morocco

Lemmih,

Bakzaza,

Errachidi

et al. 2024

International Journal of Environmental Studies

View full text Add to dashboard Cite

Clinical, Prognostic and Socio-Economic Aspects of T4 Breast Cancers in Ouagadougou, Burkina Faso: A Retrospective Study

Bambara,

Kabore,

Ilboudo

et al. 2023

ABCR

View full text Add to dashboard Cite

Breast cancers classified T4 according to the TNM code are frequent in Burkina Faso. A better knowledge of these cancers would help to better organize the fight against breast cancer in general. We conducted this study to present the clinical and prognostic aspects of T4 breast cancer in Ouagadougou. It was a descriptive retrospective study based on the medical record of patients received from January 1, 2017 to December 31, 2021 in the cancer department of Yalgado Ouedraogo University Hospital. Patients followed for histologically confirmed breast cancer who were classified in the cT4 category of the TNM code 8e edition were included. We collected a total of 286 patients. Non-salaried patients accounted for 90.56%. In this study, 53.3% of patients lived in urban area and 36.7% in rural area. Menopausal patients accounted for 56.8% of cases. One hundred and thirty-three (46.5%) patients were overweight or obese and 121 (42.3%) patients had a normal weight. The average consultation time, which is the time between the first signs and consultation in a specialized center, was 12 months, with a median of 11 months. According to category T of the TNM code, 19 patients (6.6%) were classified T4d, 176 (61.5%) were classified T4c, 69 (24.1%) were classified T4b and 22 (7.7%) T4a. One hundred and twenty patients (42%) were metastatic. The median overall survival of all patients in our sample was 20 months. In univariate analysis, metastatic status was risk factor for death, while obesity and surgery were protective factors. In multivariate analysis, obesity, surgery and metastatic status were independently associated with survival; obesity and surgery were protective factors. Survival is poor due to advanced stages and difficulties in the management of these cancers. Measures to facilitate access to care would improve the prognosis of these cancers.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Breast Cancer in Bobo-Dioulasso, Burkina Faso: Management OutcomesLe Cancer du Sein �Bobo-Dioulasso, Burkina Faso : R閟ultats de la Prise en Charge

Cited by 4 publications

References 15 publications

Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa

Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa

The quality of life among women with breast cancer: a qualitative study in the environment of healthcare in Morocco

Clinical, Prognostic and Socio-Economic Aspects of T4 Breast Cancers in Ouagadougou, Burkina Faso: A Retrospective Study

Contact Info

Product

Resources

About